2011 WHO Gonococcal Antimicrobial Surveillance Programme Western Pacific region (WPR) data showing the number of isolates tested in each participating country, the proportion of isolates resistant to penicillin, ciprofloxacin and azithromycin, and decreased susceptibility to ceftriaxone (MIC >/=0.06 mg/L). Data provided by the WHO Collaborating Centre Sydney
| Country WPR 2011 | Number of isolates tested | Decreased susceptibility | Resistance | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ceftriaxone | Ciprofloxacin | Azithromycin | Penicillin | ||||||
| No. | % | No. | % | No. | % | No. | % | ||
| Australia (Urban) | 3647 | 132 | 3.6 | 1116 | 31 | 48 | 1.3 | 1034 | 28 |
| Australia (Remote) | 459 | 2 | 0.4 | 16 | 3.5 | 1 | 0.2 | 19 | 4.1 |
| Brunei Darussalam | 295 | 3 | 1.0 | 263 | 89 | NT | NT | 194 | 66 |
| China | 1349 | 288 | 21 | 1341 | 99 | NT | NT | 584* | 43 |
| Fiji | 252† | 0 | 0 | 0 | 0 | NT | NT | 17 | 6.7 |
| Hong Kong (China)‡ | 1225 | 19 | 1.6 | 1213 | 99 | 48 | 3.9 | 666 | 54 |
| Japan | 441 | 21 | 4.8 | 332 | 75 | NT | NT | 198 | 45 |
| The Republic of Korea | 64 | 16 | 25 | 57 | 89 | NT | NT | 32 | 50 |
| New Caledonia‡ | 166 | NT | NT | 10 | 6.0 | NT | NT | 15 | 9.0 |
| New Zealand | 317 | 10 | 3.2 | 143 | 45 | NT | NT | 91 | 29 |
| The Philippines | 34 | 0 | 0 | 32 | 94 | NT | NT | 29 | 85 |
| Singapore | 160 | 11 | 6.9 | 134 | 84 | NT | NT | 97 | 61 |
| Vietnam | 75 | 1 | 1.3 | 72 | 96 | 1 | 1.3 | 37 | 49 |
| Total | 8484 | 503 | 6.2 | 4729 | 57 | 98 | 1.2 | 3013 | 36 |
*From China 584 of 1349 (43.3%) isolates were penicillin resistant by β-lactamase (PPNG). Gonococci with chromosomally mediated resistance to penicillin (CMRP) were not reported.
†In Fiji only strains that are penicillin resistant are tested for ceftriaxone and ciprofloxacin susceptibility (n=17 in 2011).
‡Area of the Western Pacific Region.
NT, not tested.